This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Biopharmaceutical company Ilypsa (formerly Symyx Therapeutics, a 2003 spin-out from Symyx Technologies) raised $36mm in a Series B round co-led by new investors US Venture Partners, Johnson & Johnson Development Corp., and Delphi Ventures. Also participating in the financing were other new investors CMEA Ventures and Mediphase Venture Partners, along with existing backers Sprout Group and 5AM Ventures.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?